Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05751603Not yet recruiting
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: extubation quality score. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05751603.